How high-density lipoprotein protects against the effects of lipid peroxidation
- 1 August 2000
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Lipidology
- Vol. 11 (4) , 383-388
- https://doi.org/10.1097/00041433-200008000-00007
Abstract
The protective effect of HDL against the development of atherosclerosis appears to be multifaceted involving a number of mechanisms. One of the major mechanisms is, however, the ability of HDL to decrease, directly or indirectly, the lipid peroxidation of LDL. The hydrolysis of lipid peroxides by PON1 makes a major contribution to this effect of HDL. Evidence is accumulating that the PON1 activity of human serum can be modulated by a variety of natural compounds and that these may increase or decrease the protective ability of PON1 and therefore of HDL on which it is exclusively located. Modulations of PON1 that enhance its activity may help to delay the atherosclerotic process.Keywords
This publication has 57 references indexed in Scilit:
- Regression of Atherosclerosis Induced by Liver-Directed Gene Transfer of Apolipoprotein A-I in MiceCirculation, 1999
- Biologically Active Oxidized PhospholipidsPublished by Elsevier ,1999
- Apo A-I inhibits foam cell formation in apo E–deficient mice after monocyte adherence to endotheliumJournal of Clinical Investigation, 1999
- Somatic Gene Transfer of Human ApoA-I Inhibits Atherosclerosis Progression in Mouse ModelsCirculation, 1999
- Oxidized Low-Density Lipoprotein, a Two-Faced Janus in Coronary Artery Disease?Biochemical Pharmacology, 1998
- High-Density Lipoprotein Cholesterol and Risk of Ischemic Stroke MortalityStroke, 1997
- High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transportAtherosclerosis, 1996
- Book ReviewAmbulatory Pediatric CareNew England Journal of Medicine, 1989
- Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham StudyJAMA, 1986
- PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASEThe Lancet, 1975